found in vitro that OSM treatment promoted JAK/STAT pathway activation by inducing JAK and STAT phosphorylation in RA-FLS, and also induced RA-FLS to secrete the pro-inflammatory cytokine IL-6 by activating the MAPK pathway (64). This evidence concerns the gene SOAT1 and rheumatoid arthritis.